Who invested in Avalo Therapeutics?
Avalo Therapeutics's investors include OrbiMed, RA Capital Management, TCG and TCG Crossover.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$501Mraised across 2 rounds since 2024, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From Avalo Therapeutics's own website and the SEC filings it signed: 8 on the team.
On the board, as filediAaron KantoffGilla KaplanJonathan GoldmanJune AlmenoffMagnus PerssonMitchell ChanSamantha Truex
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Avalo Therapeutics's investors include OrbiMed, RA Capital Management, TCG and TCG Crossover.
Avalo Therapeutics has raised $501M across 2 rounds since 2024.
Avalo Therapeutics's most recent round was an Undisclosed round of $431M in May 2026.
Its most recent round, $431M in May 2026, is also its largest on record.
Avalo Therapeutics's first round on record, in Nov 2024, was backed by OrbiMed, RA Capital Management and TCG and 1 others.
Avalo Therapeutics's latest named round is an Undisclosed round, in May 2026.
Avalo Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.